Metabolic syndrome, redox state, and the proteasomal system

Antioxidants and Redox Signaling

Volumn 25, Issue 16, 2016, Pages 902-917

  Höhn, Annika ^a,b   König, Jeannette ^a   Jung, Tobias ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

inflammation; metabolism; nutrition; proteasome; redox; ROS

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYTOKINE; PROTEASOME; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; UBIQUITIN;

CYTOKINE RELEASE; ENDOPLASMIC RETICULUM STRESS; HUMAN; INFLAMMATION; LIPID PEROXIDATION; METABOLIC SYNDROME X; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN HOMEOSTASIS; REVIEW; UNFOLDED PROTEIN RESPONSE; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION; PHENOTYPE; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UBIQUITIN;

EID: 85002198139     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2016.6815     Document Type: Review

References (78)

1. Abella V, Scotece M, Conde J, Lopez V, Lazzaro V, Pino J, Gomez-Reino JJ, and Gualillo O. Adipokines, metabolic syndrome and rheumatic diseases. J Immunol Res 2014: 343746, 2014.
2. Amirkhizi F, Siassi F, Djalali M, and Shahraki SH. Impaired enzymatic antioxidant defense in erythrocytes of women with general and abdominal obesity. Obes Res Clin Pract 8: e26-e34, 2014.
3. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, and Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56: 952-964, 2012.
4. Bhaswant M, Poudyal H, and Brown L. Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids. J Nutr Biochem 26: 571-584, 2015.
5. Bonomini F, Rodella LF, and Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis 6: 109-120, 2015.
6. Clerico EM, Tilitsky JM, Meng W, and Gierasch LM. How hsp70 molecular machines interact with their substrates to mediate diverse physiological functions. J Mol Biol 427: 1575-1588, 2015.
7. Cristancho AG and Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12: 722-734, 2011.
8. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, and Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99: 224-229, 1999.
9. Demasi M, Netto LE, Silva GM, Hand A, de Oliveira CL, Bicev RN, Gozzo F, Barros MH, Leme JM, and Ohara E. Redox regulation of the proteasome via S-glutathionylation. Redox Biol 2: 44-51, 2014.
10. Demasi M, Shringarpure R, and Davies KJ. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch Biochem Biophys 389: 254-263, 2001.
11. Demasi M, Silva GM, and Netto LE. 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J Biol Chem 278: 679-685, 2003.
12. Ferrario CM and Strawn WB. Role of the renin-angiotensinaldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98: 121-128, 2006.
13. Forstermann U and Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714, 2006.
14. Fort P, Kajava AV, Delsuc F, and Coux O. Evolution of proteasome regulators in eukaryotes. Genome Biol Evol 7: 1363-1379, 2015.
15. Foss GS and Prydz H. Interferon regulatory factor 1 mediates the interferon-gamma induction of the human immunoproteasome subunit multicatalytic endopeptidase complex-like 1. J Biol Chem 274: 35196-35202, 1999.
16. Frossi B, De Carli M, Daniel KC, Rivera J, and Pucillo C. Oxidative stress stimulates IL-4 and IL-6 production in mast cells by an APE/Ref-1-dependent pathway. Eur J Immunol 33: 2168-2177, 2003.
17. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761, 2004.
18. Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewari-Singh N, Capobianco S, Chilian WM, and Zhang C. Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 115: 245-254, 2007.
19. Giacco F and Brownlee M. Oxidative stress and diabetic complications. Circ Res 107: 1058-1070, 2010.
20. Grimm S, Ott C, Horlacher M, Weber D, Hohn A, and Grune T. Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1. Biochem J 448: 127-139, 2012.
21. Grune T, Catalgol B, Licht A, Ermak G, Pickering AM, Ngo JK, and Davies KJ. HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic Biol Med 51: 1355-1364, 2011.
22. Hamblin M, Smith HM, and Hill MF. Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione. J Card Fail 13: 884-892, 2007.
23. Heink S, Ludwig D, Kloetzel PM, and Kruger E. IFNgamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A 102: 9241-9246, 2005.
24. Hohn TJ and Grune T. The proteasome and the degradation of oxidized proteins: part III-Redox regulation of the proteasomal system. Redox Biol 2: 388-394, 2014.
25. Huang Y, Li W, Su ZY, and Kong AT. The complexity of the Nrf2 pathway: beyond the antioxidant response. J Nutr Biochem 26: 1401-1413, 2015.
26. Hukshorn CJ, Lindeman JH, Toet KH, Saris WH, Eilers PH, Westerterp-Plantenga MS, and Kooistra T. Leptin and the proinflammatory state associated with human obesity. J Clin Endocrinol Metab 89: 1773-1778, 2004.
27. Husain K, Hernandez W, Ansari RA, and Ferder L. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem 6: 209-217, 2015.
28. Ichihara A and Tanaka K. Roles of proteasomes in cell growth. Mol Biol Rep 21: 49-52, 1995.
29. Ishii T, Sakurai T, Usami H, and Uchida K. Oxidative modification of proteasome: identification of an oxidationsensitive subunit in 26 S proteasome. Biochemistry 44: 13893-13901, 2005.
30. Jang J, Wang Y, Kim HS, Lalli MA, and Kosik KS. Nrf2, a regulator of the proteasome, controls self-renewal and pluripotency in human embryonic stem cells. Stem Cells 32: 2616-2625, 2014.
31. Jung T, Bader N, and Grune T. Oxidized proteins: intracellular distribution and recognition by the proteasome. Arch Biochem Biophys 462: 231-237, 2007.
32. Jung T, Catalgol B, and Grune T. The proteasomal system. Mol Aspects Med 30: 191-296, 2009.
33. Jung T, Engels M, Kaiser B, and Grune T. Distribution of oxidized and HNE-modified proteins in U87 cells. Biofactors 24: 165-170, 2005.
34. Jung T, Engels M, Kaiser B, Poppek D, and Grune T. Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress. Free Radic Biol Med 40: 1303-1312, 2006.
35. Jung T, Engels M, Klotz LO, Kroncke KD, and Grune T. Nitrotyrosine and protein carbonyls are equally distributed in HT22 cells after nitrosative stress. Free Radic Biol Med 42: 773-786, 2007.
36. Jung T and Grune T. Structure of the proteasome. Prog Mol Biol Transl Sci 109: 1-39, 2012.
37. Jung T and Grune T. The proteasome and the degradation of oxidized proteins: part I-structure of proteasomes. Redox Biol 1: 178-182, 2013.
38. Jung T, Hohn A, Catalgol B, and Grune T. Age-related differences in oxidative protein-damage in young and senescent fibroblasts. Arch Biochem Biophys 483: 127-135, 2009.
39. Jung T, Hohn A, and Grune T. The proteasome and the degradation of oxidized proteins: part II-protein oxidation and proteasomal degradation. Redox Biol 2C: 99-104, 2013.
40. Kapadia MR, Eng JW, Jiang Q, Stoyanovsky DA, and Kibbe MR. Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells. Nitric Oxide 20: 279-288, 2009.
41. Kapeta S, Chondrogianni N, and Gonos ES. Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts. J Biol Chem 285: 8171-8184, 2010.
42. Khodabandeloo H, Gorgani-Firuzjaee S, Panahi S, and Meshkani R. Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction. Transl Res 167: 228-256, 2016.
43. Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, and Kensler TW. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23: 8786-8794, 2003.
44. Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, and Kong AN. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol 76: 1485-1489, 2008.
45. Liu H, Yu S, Xu W, and Xu J. Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus. Arterioscler Thromb Vasc Biol 32: 2131-2140, 2012.
46. Lonardo A, Ballestri S, Marchesini G, Angulo P, and Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis 47: 181-190, 2015.
47. Marseglia L, Manti S, DAngelo G, Nicotera A, Parisi E, Di Rosa G, Gitto E, and Arrigo T. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 16: 378-400, 2015.
48. Matsuda M and Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 7: e330-e341, 2013.
49. May JM and de Haen C. The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem 254: 9017-9021, 1979.
50. Mishto M, Santoro A, Bellavista E, Sessions R, Textoris-Taube K, Dal Piaz F, Carrard G, Forti K, Salvioli S, Friguet B, Kloetzel PM, Rivett AJ, and Franceschi C. A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms. Biol Chem 387: 417-429, 2006.
51. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, and Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178: 1748-1758, 2007.
52. Murata S, Sasaki K, Kishimoto T, Niwa S, Hayashi H, Takahama Y, and Tanaka K. Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 316: 1349-1353, 2007.
53. Naugler WE and Karin M. The wolf in sheeps clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 14: 109-119, 2008.
54. Nitta T, Murata S, Sasaki K, Fujii H, Ripen AM, Ishimaru N, Koyasu S, Tanaka K, and Takahama Y. Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells. Immunity 32: 29-40, 2010.
55. Ottum MS and Mistry AM. Advanced glycation endproducts: modifiable environmental factors profoundly mediate insulin resistance. J Clin Biochem Nutr 57: 1-12, 2015.
56. Pacurari M, Kafoury R, Tchounwou PB, and Ndebele K. The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam 2014: 689360, 2014.
57. Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, and Davies KJ. The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 432: 585-594, 2010.
58. Pickering AM, Linder RA, Zhang H, Forman HJ, and Davies KJ. Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress. J Biol Chem 287: 10021-10031, 2012.
59. Ramachandran S, Liaw JM, Jia J, Glasgow SC, Liu W, Csontos K, Upadhya GA, Mohanakumar T, and Chapman WC. Ischemia-reperfusion injury in rat steatotic liver is dependent on NFkappaB P65 activation. Transpl Immunol 26: 201-206, 2012.
60. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ, and Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335(Pt 3): 637-642, 1998.
61. Ristic G, Tsou WL, and Todi SV. An optimal ubiquitinproteasome pathway in the nervous system: the role of deubiquitinating enzymes. Front Mol Neurosci 7: 72, 2014.
62. Sha Z and Goldberg AL. Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97. Curr Biol 24: 1573-1583, 2014.
63. Shang F and Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic Biol Med 51: 5-16, 2011.
64. Silva GM, Netto LE, Simoes V, Santos LF, Gozzo FC, Demasi MA, Oliveira CL, Bicev RN, Klitzke CF, Sogayar MC, and Demasi M. Redox control of 20S proteasome gating. Antioxid Redox Signal 16: 1183-1194, 2012.
65. Tanaka K and Ichihara A. Autodegradation of rat liver proteasomes (large multicatalytic proteinase complexes). Biochem Biophys Res Commun 158: 548-554, 1989.
66. Tanaka K and Ichihara A. Half-life of proteasomes (multiprotease complexes) in rat liver. Biochem Biophys Res Commun 159: 1309-1315, 1989.
67. Than A, Zhang X, Leow MK, Poh CL, Chong SK, and Chen P. Apelin attenuates oxidative stress in human adipocytes. J Biol Chem 289: 3763-3774, 2014.
68. Trumpower BL. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J Biol Chem 265: 11409-11412, 1990.
69. Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, and Davies KJ. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci U S A 96: 6223-6228, 1999.
70. Uruno A, Yagishita Y, and Yamamoto M. The Keap1-Nrf2 system and diabetes mellitus. Arch Biochem Biophys 566: 76-84, 2015.
71. Voigt A, Rahnefeld A, Kloetzel PM, and Kruger E. Cytokine-induced oxidative stress in cardiac inflammation and heart failure-how the ubiquitin proteasome system targets this vicious cycle. Front Physiol 4: 42, 2013.
72. Wang S, Zhang M, Liang B, Xu J, Xie Z, Liu C, Viollet B, Yan D, and Zou MH. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res 106: 1117-1128, 2010.
73. Wang Y, Sun W, Du B, Miao X, Bai Y, Xin Y, Tan Y, Cui W, Liu B, Cui T, Epstein PN, Fu Y, and Cai L. Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-kappaB. Am J Physiol Heart Circ Physiol 304: H567-H578, 2013.
74. Xing Y, Jameson SC, and Hogquist KA. Thymoproteasome subunit-beta5T generates peptide-MHC complexes specialized for positive selection. Proc Natl Acad Sci U S A 110: 6979-6984, 2013.
75. Yan LJ. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. J Diabetes Res 2014: 137919, 2014.
76. Yang Z, Gagarin D, St Laurent G, III, Hammell N, Toma I, Hu CA, Iwasa A, and McCaffrey TA. Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome. Arterioscler Thromb Vasc Biol 29: 1213-1219, 2009.
77. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, and Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet 368: 1681-1688, 2006.
78. Zmijewski JW, Banerjee S, and Abraham E. Sglutathionylation of the Rpn2 regulatory subunit inhibits 26 S proteasomal function. J Biol Chem 284: 22213-22221, 2009.